Calumet Specialty Products
CLMT
70 hedge funds and large institutions have $213M invested in Calumet Specialty Products in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 8 closing their positions.
150% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 8
148% more call options, than puts
Call options by funds: $31.1M | Put options by funds: $12.6M
71% more capital invested
Capital invested by funds: $125M → $213M (+$88.3M)
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
17% more funds holding
Funds holding: 60 → 70 (+10)
0.3% more ownership
Funds ownership: 20.1% → 20.4% (+0.3%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$3.81M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.21M |
| 3 |
SM
SG3 Management
Dorado,
Puerto Rico
|
+$2.13M |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$1.96M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.73M |
Top Sellers
| 1 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$9.69M |
| 2 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
-$8.5M |
| 3 |
Goldman Sachs
New York
|
-$4.29M |
| 4 |
Barclays
London,
United Kingdom
|
-$1.72M |
| 5 |
SCM
Springhouse Capital Management
Westport,
Connecticut
|
-$1.12M |
CLMT Hedge Fund Activity: Q4 2021 in Review
70 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q4 2021, worth a combined $213M — up 71% from $125M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CLMT positions and 8 closed out — a net gain of 12 holders — while 21 added to existing stakes and 16 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.81M. The largest seller was Caption Management, exiting entirely with an estimated $9.69M sold.
- 70 institutional investors held Calumet Specialty Products (CLMT) as of Q4 2021, up from 60 in Q3 2021.
- Funds reported $213M of Calumet Specialty Products stock for Q4 2021, up 71% quarter-over-quarter.
- 20 funds opened new Calumet Specialty Products positions in Q4 2021 and 8 closed out, a net change of +12 holders.
- The largest Calumet Specialty Products buyer in Q4 2021 was Morgan Stanley, an estimated $3.81M added.
- The largest Calumet Specialty Products seller in Q4 2021 was Caption Management, an estimated $9.69M sold.
Based on aggregated 13F filings for Q4 2021.